Nivolumab in Resected and Unresectable Metastatic Melanoma: Characteristics of Immune-Related Adverse Events and Association with Outcomes. (Q36586109)
Jump to navigation
Jump to search
scientific article published on 7 October 2015
Language | Label | Description | Also known as |
---|---|---|---|
English | Nivolumab in Resected and Unresectable Metastatic Melanoma: Characteristics of Immune-Related Adverse Events and Association with Outcomes. |
scientific article published on 7 October 2015 |
Statements
Nivolumab in Resected and Unresectable Metastatic Melanoma: Characteristics of Immune-Related Adverse Events and Association with Outcomes (English)
Morganna Freeman-Keller
Youngchul Kim
Heather Cronin
Allison Richards
Geoffrey Gibney
7 October 2015
1 reference